Lantheus (LNTH) Revenue & Revenue Breakdown
Lantheus Revenue Highlights
Latest Revenue (Y)
$1.30B
Latest Revenue (Q)
$378.73M
Main Segment (Y)
Product
Main Geography (Y)
US Segment
Lantheus Revenue by Period
Lantheus Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $1.30B | 38.65% |
2022-12-31 | $935.06M | 119.91% |
2021-12-31 | $425.21M | 25.28% |
2020-12-31 | $339.41M | -2.28% |
2019-12-31 | $347.34M | 1.15% |
2018-12-31 | $343.37M | 3.62% |
2017-12-31 | $331.38M | 9.78% |
2016-12-31 | $301.85M | 2.86% |
2015-12-31 | $293.46M | -2.70% |
2014-12-31 | $301.60M | 6.32% |
2013-12-31 | $283.67M | -1.54% |
2012-12-31 | $288.11M | -19.14% |
2011-12-31 | $356.29M | - |
Lantheus Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $378.73M | -3.90% |
2024-06-30 | $394.09M | 6.52% |
2024-03-31 | $369.98M | 4.51% |
2023-12-31 | $354.00M | 10.64% |
2023-09-30 | $319.95M | -0.55% |
2023-06-30 | $321.70M | 6.95% |
2023-03-31 | $300.78M | 14.29% |
2022-12-31 | $263.17M | 9.98% |
2022-09-30 | $239.29M | 6.96% |
2022-06-30 | $223.72M | 7.11% |
2022-03-31 | $208.88M | 61.22% |
2021-12-31 | $129.56M | 26.93% |
2021-09-30 | $102.07M | 1.00% |
2021-06-30 | $101.06M | 9.25% |
2021-03-31 | $92.51M | -1.75% |
2020-12-31 | $94.15M | 6.33% |
2020-09-30 | $88.54M | 34.14% |
2020-06-30 | $66.01M | -27.22% |
2020-03-31 | $90.70M | 1.52% |
2019-12-31 | $89.35M | 4.16% |
2019-09-30 | $85.78M | 0.08% |
2019-06-30 | $85.70M | -0.93% |
2019-03-31 | $86.51M | 0.28% |
2018-12-31 | $86.27M | -2.96% |
2018-09-30 | $88.90M | 3.89% |
2018-06-30 | $85.57M | 3.56% |
2018-03-31 | $82.63M | 1.71% |
2017-12-31 | $81.24M | 1.63% |
2017-09-30 | $79.94M | -10.01% |
2017-06-30 | $88.84M | 9.19% |
2017-03-31 | $81.36M | 9.43% |
2016-12-31 | $74.35M | 1.76% |
2016-09-30 | $73.06M | -6.29% |
2016-06-30 | $77.97M | 1.95% |
2016-03-31 | $76.47M | 7.41% |
2015-12-31 | $71.20M | -3.94% |
2015-09-30 | $74.12M | 1.10% |
2015-06-30 | $73.31M | -2.02% |
2015-03-31 | $74.82M | -2.79% |
2014-12-31 | $76.97M | 1.70% |
2014-09-30 | $75.68M | 0.09% |
2014-06-30 | $75.61M | 3.10% |
2014-03-31 | $73.34M | 2.33% |
2013-12-31 | $71.67M | 1.82% |
2013-09-30 | $70.39M | -0.31% |
2013-06-30 | $70.60M | -0.59% |
2013-03-31 | $71.02M | - |
Lantheus Revenue Breakdown
Lantheus Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
PYLARIFY | $851.30M | $527.40M | $43.41M | - | - |
Product | $1.26B | - | - | - | - |
Total Precision Diagnostics | $390.12M | $356.68M | $351.02M | - | - |
Techne Lite | $87.37M | $88.86M | $91.29M | - | - |
Other Precision Diagnostics | $22.98M | $22.82M | $26.97M | - | - |
License and Royalty Revenues | $33.36M | $48.02M | $24.85M | - | - |
DEFINITY | $279.77M | $244.99M | $232.76M | - | - |
Radiopharmaceutical Oncology | $854.43M | $531.51M | $48.89M | - | - |
Strategic Partnerships And Other | $51.88M | $46.87M | $25.30M | - | - |
Other Radiopharmaceutical Oncology | $3.13M | $4.10M | $5.47M | - | - |
Product Revenue, Net | - | $887.04M | $400.36M | - | - |
US Segment | - | - | - | $294.80M | $303.99M |
International Segment | - | - | - | $44.61M | $43.35M |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Techne Lite | $20.48M | $28.19M | $21.71M | $23.27M | $21.59M | $20.99M | $24.73M | $22.09M | $19.44M | $22.61M | $22.04M | $22.68M | $23.77M | $22.80M | - | - | - | - | - | - |
Total Precision Diagnostics | $103.73M | $112.11M | $104.21M | $96.35M | $97.58M | $95.62M | $94.37M | $89.01M | $87.11M | $86.20M | $87.04M | $87.88M | $90.36M | $85.75M | - | - | - | - | - | - |
DEFINITY | $76.97M | $78.10M | $76.56M | $67.34M | $70.53M | $68.82M | $63.62M | $60.74M | $62.31M | $58.33M | $59.31M | $57.64M | $59.84M | $55.97M | - | - | - | - | - | - |
License and Royalty Revenues | $4.13M | $1.33M | $662.00K | $438.00K | $7.62M | $8.53M | $7.29M | $5.93M | $5.94M | $28.87M | $6.76M | $5.39M | $7.50M | $5.19M | - | - | - | - | - | - |
Other Precision Diagnostics | $6.28M | $5.83M | $5.93M | $5.74M | $5.45M | $5.81M | $6.02M | $6.17M | $5.36M | $5.26M | $5.68M | $7.56M | $6.74M | $6.98M | - | - | - | - | - | - |
PYLARIFY | $259.76M | $273.25M | $258.87M | $215.43M | $210.52M | $195.47M | $160.64M | $143.75M | $130.23M | $92.78M | - | - | - | - | - | - | - | - | - | - |
Product | $374.60M | $392.76M | $369.31M | $319.51M | $314.08M | $292.26M | $233.37M | $217.78M | $180.01M | $96.68M | $93.56M | $87.32M | - | - | - | - | - | - | - | - |
Radiopharmaceutical Oncology | $259.76M | $273.25M | $259.25M | $216.28M | $211.34M | $196.19M | $161.56M | $144.68M | $131.16M | $94.10M | $35.68M | $8.89M | $2.81M | $1.50M | - | - | - | - | - | - |
Strategic Partnerships And Other | $15.25M | $8.72M | $6.51M | $7.32M | $12.78M | $8.98M | $7.24M | $5.60M | $5.45M | $28.58M | $6.84M | $5.30M | $7.90M | $5.25M | - | - | - | - | - | - |
Other Radiopharmaceutical Oncology | - | - | $384.00K | $848.00K | $818.00K | $717.00K | $919.00K | $928.00K | $928.00K | $1.33M | - | - | - | - | - | - | - | - | - | - |
International Segment | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $12.97M | $11.07M | $8.61M | $11.96M | $10.63M | $11.13M |
US Segment | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $81.18M | $77.47M | $57.40M | $78.75M | $78.72M | $74.65M |
Latest
Lantheus Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 20 | Dec 19 | Dec 18 |
---|---|---|---|
US Segment | $294.80M | $72.53M | - |
Worldwide | - | $347.34M | - |
UNITED STATES | - | - | $288.58M |
All Other | - | - | $54.79M |
Latest
Quarterly Revenue by Country
Country | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
US Segment | $81.18M | $77.47M | $57.40M | $19.36M | $78.72M | $74.65M | $75.19M | $75.43M | $72.75M | $70.25M | $74.09M | $71.49M |
Latest
Lantheus Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
RDY | Dr. Reddy's Laboratories | $279.16B | - |
CTLT | Catalent | $4.38B | $1.02B |
NBIX | Neurocrine Biosciences | $1.89B | $622.10M |
ALKS | Alkermes | $1.66B | $378.14M |
LNTH | Lantheus | $1.30B | $378.73M |
PCRX | Pacira BioSciences | $674.98M | $168.57M |
AMPH | Amphastar Pharmaceuticals | $593.24M | $188.82M |
COLL | Collegium Pharmaceutical | $566.77M | $159.30M |
ANIP | ANI Pharmaceuticals | $486.82M | $148.33M |
IRWD | Ironwood Pharmaceuticals | $442.74M | $91.59M |
DVAX | Dynavax | $232.28M | $79.34M |
DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
DERM | Journey Medical | $79.18M | $14.86M |
AQST | Aquestive Therapeutics | $50.58M | $13.54M |
AVDL | Avadel Pharmaceuticals | $27.96M | $50.02M |